Vanberra Signal

NeuroVision

Curated by Signal

AI based retinal imaging analysis for Alzheimer's and eye disease

Overview

NeuroVision is an integrated neuroscience company that focuses on designing diagnostic tests and biomarkers for early detection and monitoring of amyloid pathology related to Alzheimer’s disease. The company has developed a retinal imaging technology named Afina, that assists with visualization and measurement of retinal health. It uses the datasets, to provide data aggregation services, analysis, biostatistics, and applies machine learning algorithms to the images and other biomarker data for understanding and prediction of neurodegenerative diseases.

Key facts

Founded
2010

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Developer of sleep and oximetry monitoring devices

    Health TechnologyColumbus, United States
  • AI-powered platform for healthcare organizations for data and marketing management

    Health TechnologySan Francisco, United States
  • Provider of online platform for medications

    Health TechnologyHoover, United States

About NeuroVision

What does NeuroVision do?

NeuroVision is an integrated neuroscience company that focuses on designing diagnostic tests and biomarkers for early detection and monitoring of amyloid pathology related to Alzheimer’s disease.

Where is NeuroVision headquartered?

NeuroVision is headquartered in Sacramento, United States.

When was NeuroVision founded?

NeuroVision was founded in 2010.

Which sector is NeuroVision in?

NeuroVision operates in Health Technology.

Who are NeuroVision's competitors?

Companies similar to NeuroVision include Patient Safety, RadiantGraph, and Inspire Organics.